Advertisement
Screener

ProQR Therapeutics N.V. (PRQR) Increase Decrease Through Share-based Payment Transactions

2.8 / 5 stars · 68/120 Roast Me

ProQR Therapeutics N.V. Increase Decrease Through Share-based Payment Transactions

ProQR Therapeutics N.V. (PRQR) reported Increase Decrease Through Share-based Payment Transactions of EUR 4.01 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-12.

Financial Statements › Notes › Compensation Related Costs

ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions · last filed 2026-03-12

  • ProQR Therapeutics N.V. increase decrease through share-based payment transactions for the quarter ending 2025-12-31 was 1.23M EUR, a 116.55% increase year-over-year.
  • ProQR Therapeutics N.V. increase decrease through share-based payment transactions for the quarter ending 2025-09-30 was 1.12M EUR, a 82.52% increase year-over-year.
  • ProQR Therapeutics N.V. increase decrease through share-based payment transactions for the quarter ending 2025-06-30 was 909.00K EUR, a 44.75% increase year-over-year.
  • ProQR Therapeutics N.V. increase decrease through share-based payment transactions for the quarter ending 2025-03-31 was 758.00K EUR, a 2.99% increase year-over-year.
Period endIncrease Decrease Through Share-based Payment Transactions 3 monthIncrease Decrease Through Share-based Payment Transactions 6 monthIncrease Decrease Through Share-based Payment Transactions 9 monthIncrease Decrease Through Share-based Payment Transactions 12 month
2025-12-311.23M EUR
derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12
2.35M EUR
derived: sum of 2 quarters · filed 2026-03-12
3.26M EUR
derived: sum of 3 quarters · filed 2026-03-12
4.01M EUR
20-F · filed 2026-03-12
2025-09-301.12M EUR
derived: 6-K 9 month − 6-K 6 month · filed 2025-11-06
2.03M EUR
derived: sum of 2 quarters · filed 2025-11-06
2.78M EUR
6-K · filed 2025-11-06
3.35M EUR
derived: sum of 4 quarters · filed 2026-03-12
2025-06-30909.00K EUR
derived: 6-K 6 month − 6-K 3 month · filed 2025-08-07
1.67M EUR
6-K · filed 2025-08-07
2.23M EUR
derived: sum of 3 quarters · filed 2026-03-12
2.85M EUR
derived: sum of 4 quarters · filed 2026-03-12
2025-03-31758.00K EUR
6-K · filed 2025-05-08
1.33M EUR
derived: sum of 2 quarters · filed 2026-03-12
1.94M EUR
derived: sum of 3 quarters · filed 2026-03-12
2.57M EUR
derived: sum of 4 quarters · filed 2026-03-12
2024-12-31568.00K EUR
derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12
1.18M EUR
derived: sum of 2 quarters · filed 2026-03-12
1.81M EUR
derived: sum of 3 quarters · filed 2026-03-12
2.54M EUR
20-F · filed 2026-03-12
2024-09-30612.00K EUR
derived: 6-K 9 month − 6-K 6 month · filed 2025-11-06
1.24M EUR
derived: sum of 2 quarters · filed 2025-11-06
1.98M EUR
6-K · filed 2025-11-06
2.78M EUR
derived: sum of 4 quarters · filed 2026-03-12
2024-06-30628.00K EUR
derived: 6-K 6 month − 6-K 3 month · filed 2025-08-07
1.36M EUR
6-K · filed 2025-08-07
2.17M EUR
derived: sum of 3 quarters · filed 2026-03-12
2.61M EUR
derived: sum of 4 quarters · filed 2026-03-12
2024-03-31736.00K EUR
6-K · filed 2025-05-08
1.54M EUR
derived: sum of 2 quarters · filed 2026-03-12
1.98M EUR
derived: sum of 3 quarters · filed 2026-03-12
2.75M EUR
derived: sum of 4 quarters · filed 2026-03-12
2023-12-31802.00K EUR
derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12
1.25M EUR
derived: sum of 2 quarters · filed 2026-03-12
2.01M EUR
derived: sum of 3 quarters · filed 2026-03-12
3.11M EUR
20-F · filed 2026-03-12
2023-09-30444.00K EUR
derived: 6-K 9 month − 6-K 6 month · filed 2024-11-07
1.21M EUR
derived: sum of 2 quarters · filed 2024-11-07
2.30M EUR
6-K · filed 2024-11-07
1.92M EUR
derived: sum of 4 quarters · filed 2025-03-13
2023-06-30765.00K EUR
derived: 6-K 6 month − 6-K 3 month · filed 2024-08-08
1.86M EUR
6-K · filed 2024-08-08
1.47M EUR
derived: sum of 3 quarters · filed 2025-03-13
2.81M EUR
derived: sum of 4 quarters · filed 2025-03-13
2023-03-311.09M EUR
6-K · filed 2024-05-09
708.00K EUR
derived: sum of 2 quarters · filed 2025-03-13
2.04M EUR
derived: sum of 3 quarters · filed 2025-03-13
2.78M EUR
derived: sum of 4 quarters · filed 2025-03-13
2022-12-31-387.00K EUR
derived: 20-F 12 month − 6-K 9 month · filed 2025-03-13
948.00K EUR
derived: sum of 2 quarters · filed 2025-03-13
1.69M EUR
derived: sum of 3 quarters · filed 2025-03-13
2.87M EUR
20-F · filed 2025-03-13
2022-09-301.33M EUR
derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07
2.07M EUR
derived: sum of 2 quarters · filed 2023-11-07
3.26M EUR
6-K · filed 2023-11-07
5.04M EUR
derived: sum of 4 quarters · filed 2024-03-13
2022-06-30738.00K EUR
derived: 6-K 6 month − 6-K 3 month · filed 2023-08-03
1.92M EUR
6-K · filed 2023-08-03
3.70M EUR
derived: sum of 3 quarters · filed 2024-03-13
5.42M EUR
derived: sum of 4 quarters · filed 2024-03-13
2022-03-311.18M EUR
6-K · filed 2023-05-16
2.96M EUR
derived: sum of 2 quarters · filed 2024-03-13
4.68M EUR
derived: sum of 3 quarters · filed 2024-03-13
6.15M EUR
derived: sum of 4 quarters · filed 2024-03-13
2021-12-311.78M EUR
derived: 20-F 12 month − 6-K 9 month · filed 2024-03-13
3.50M EUR
derived: sum of 2 quarters · filed 2024-03-13
4.97M EUR
derived: sum of 3 quarters · filed 2024-03-13
6.60M EUR
20-F · filed 2024-03-13
2021-09-301.72M EUR
derived: 6-K 9 month − 6-K 6 month · filed 2022-11-09
3.19M EUR
derived: sum of 2 quarters · filed 2022-11-09
4.82M EUR
6-K · filed 2022-11-09
6.70M EUR
derived: sum of 4 quarters · filed 2023-03-29
2021-06-301.47M EUR
derived: 6-K 6 month − 6-K 3 month · filed 2022-08-04
3.11M EUR
6-K · filed 2022-08-04
4.98M EUR
derived: sum of 3 quarters · filed 2023-03-29
6.66M EUR
derived: sum of 4 quarters · filed 2023-03-29
2021-03-311.64M EUR
6-K · filed 2022-05-05
3.51M EUR
derived: sum of 2 quarters · filed 2023-03-29
5.19M EUR
derived: sum of 3 quarters · filed 2023-03-29
7.14M EUR
derived: sum of 4 quarters · filed 2023-03-29
2020-12-311.88M EUR
derived: 20-F 12 month − 6-K 9 month · filed 2023-03-29
3.55M EUR
derived: sum of 2 quarters · filed 2023-03-29
5.51M EUR
derived: sum of 3 quarters · filed 2023-03-29
8.38M EUR
20-F · filed 2023-03-29
2020-09-301.68M EUR
derived: 6-K 9 month − 6-K 6 month · filed 2021-11-04
3.63M EUR
derived: sum of 2 quarters · filed 2021-11-04
6.50M EUR
6-K · filed 2021-11-04
11.00M EUR
derived: sum of 4 quarters · filed 2022-04-29
2020-06-301.96M EUR
derived: 6-K 6 month − 6-K 3 month · filed 2021-08-05
4.83M EUR
6-K · filed 2021-08-05
9.32M EUR
derived: sum of 3 quarters · filed 2022-04-29
10.55M EUR
derived: sum of 4 quarters · filed 2022-04-29
2020-03-312.87M EUR
6-K · filed 2020-05-07
7.36M EUR
derived: sum of 2 quarters · filed 2022-04-29
8.59M EUR
derived: sum of 3 quarters · filed 2022-04-29
9.69M EUR
derived: sum of 4 quarters · filed 2022-04-29
2019-12-314.49M EUR
derived: 20-F 12 month − 6-K 9 month · filed 2022-04-29
5.72M EUR
derived: sum of 2 quarters · filed 2022-04-29
6.82M EUR
derived: sum of 3 quarters · filed 2022-04-29
9.11M EUR
20-F · filed 2022-04-29
2019-09-301.23M EUR
derived: 6-K 9 month − 6-K 6 month · filed 2020-11-16
2.33M EUR
derived: sum of 2 quarters · filed 2020-11-16
4.61M EUR
6-K · filed 2020-11-16
7.78M EUR
derived: sum of 4 quarters · filed 2021-03-24
2019-06-301.10M EUR
derived: 6-K 6 month − 6-K 3 month · filed 2020-08-06
3.39M EUR
6-K · filed 2020-08-06
6.56M EUR
derived: sum of 3 quarters · filed 2021-03-24
7.29M EUR
derived: sum of 4 quarters · filed 2021-03-24
2019-03-312.29M EUR
6-K · filed 2020-05-07
5.46M EUR
derived: sum of 2 quarters · filed 2021-03-24
6.19M EUR
derived: sum of 3 quarters · filed 2021-03-24
2018-12-313.17M EUR
derived: 20-F 12 month − 6-K 9 month · filed 2021-03-24
3.90M EUR
derived: sum of 2 quarters · filed 2021-03-24
5.41M EUR
20-F · filed 2021-03-24
2018-09-30734.00K EUR
derived: 6-K 9 month − 6-K 6 month · filed 2019-11-12
2.25M EUR
6-K · filed 2019-11-12
2018-06-301.51M EUR
6-K · filed 2019-08-07
2017-12-314.02M EUR
20-F · filed 2020-03-31
2017-06-302.20M EUR
6-K · filed 2018-08-08
2016-12-312.45M EUR
20-F · filed 2019-03-28
2015-12-311.21M EUR
20-F · filed 2018-03-30